Adjuvant therapy for completely resected stage II colon cancer (2008)

Peer-Reviewed Study · Figueredo A, Coombes ME, Mukherjee S (Cochrane Database Syst Rev 2008;(3):CD005390) · July 16, 2008

Figueredo A et al., 2008-07-16: Cochrane review of adjuvant chemotherapy after complete resection of stage II colon cancer. Pooled overall survival did not improve; disease-free survival did, and the authors recommend discussion of adjuvant therapy with high-risk patients rather than routine use.

Although there was no improvement in overall survival in the pooled analysis, we did find that disease-free survival in patients with stage II colon cancer was significantly better with the use of adjuvant therapy.

Abstract (AUTHORS' CONCLUSIONS)

Figueredo A et al., 2008-07-16: Cochrane review of adjuvant chemotherapy after complete resection of stage II colon cancer. Pooled overall survival did not improve; disease-free survival did, and the authors recommend discussion of adjuvant therapy with high-risk patients rather than routine use. Funder: not stated in the review text captured (no external sources listed). Declarations: 'None known'. Drugs: fluoropyrimidine-based adjuvant regimens; makers not named. Comparator: surgery alone / no adjuvant chemotherapy. Directly relevant to claims that adjuvant chemotherapy is proven to extend life in stage II disease. PMC8885310. Study type: review.